Roux-en-Y Gastric Bypass May Increase Risk for De Novo Alcohol-Related Outcomes
Investigators assessed the associations between bariatric surgery and de novo alcohol-related outcomes.
Investigators assessed the associations between bariatric surgery and de novo alcohol-related outcomes.
Liver, esophageal, endometrial and other cancers are associated with type 2 diabetes and obesity. Researchers studied whether bariatric surgery could reduce these cancer risks.
Investigators compared 4-year health care expenditures between Roux-en-Y gastric bypass and sleeve gastrectomy.
Obesity is caused by an imbalance of calories consumed vs calories expended, but researchers say there are additional risk factors at work as well.
Hypothyroidism is common in patients with obesity, but there are no clear data regarding whether patients who are taking levothyroxine should have their dosing regimen adjusted following weight loss after undergoing bariatric surgery.
Type 2 diabetes often goes into remission following weight loss after bariatric surgery. Researchers investigated whether greater amounts of weight loss were associated with higher rates of disease remission.
Obesity in people with diabetes can shorten their lifespan. Researchers compared long-term survival outcomes with regard to use of traditional weight loss methods vs bariatric surgery.
Researchers assessed how gut microbiota changes are associated with anthropometric, metabolic, and inflammatory profiles following metabolic surgery in adults with type 2 diabetes and mild obesity.
Researchers compared long-term survival outcomes of severely obese patients who underwent metabolic–bariatric surgery with those who received usual care.
Roux-en Y gastric bypass increased the likelihood of nonvertebral fractures, including hip, wrist, and pelvic fractures.